Tortoise Investment Management LLC lowered its stake in shares of Colgate-Palmolive (NYSE:CL) by 24.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,455 shares of the company’s stock after selling 1,750 shares during the period. Tortoise Investment Management LLC’s holdings in Colgate-Palmolive were worth $412,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors also recently added to or reduced their stakes in the company. Jacobi Capital Management LLC boosted its stake in shares of Colgate-Palmolive by 125.5% during the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock valued at $104,000 after purchasing an additional 803 shares during the period. Krilogy Financial LLC boosted its stake in shares of Colgate-Palmolive by 23.0% during the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after purchasing an additional 289 shares during the period. Captrust Financial Advisors purchased a new stake in shares of Colgate-Palmolive during the second quarter valued at $122,000. AlphaMark Advisors LLC boosted its stake in shares of Colgate-Palmolive by 1.5% during the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after purchasing an additional 25 shares during the period. Finally, Bruderman Asset Management LLC purchased a new stake in shares of Colgate-Palmolive during the second quarter valued at $126,000. Hedge funds and other institutional investors own 72.85% of the company’s stock.
Shares of Colgate-Palmolive (CL) traded up $0.82 during midday trading on Thursday, hitting $70.44. 1,683,252 shares of the stock were exchanged, compared to its average volume of 4,330,858. The firm has a market cap of $61,140.00, a PE ratio of 30.89, a price-to-earnings-growth ratio of 2.60 and a beta of 0.75. Colgate-Palmolive has a twelve month low of $68.03 and a twelve month high of $77.91. The company has a quick ratio of 0.34, a current ratio of 0.47 and a debt-to-equity ratio of 24.42.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be issued a $0.40 dividend. The ex-dividend date of this dividend is Monday, January 22nd. This represents a $1.60 dividend on an annualized basis and a yield of 2.27%. Colgate-Palmolive’s payout ratio is currently 70.18%.
CL has been the subject of a number of research reports. Citigroup upped their price objective on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 30th. BNP Paribas lowered shares of Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research note on Tuesday, January 30th. Jefferies Group reaffirmed a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a research note on Friday, January 26th. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a research report on Tuesday, January 16th. Finally, Macquarie raised shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target for the company in a research report on Tuesday, December 19th. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $77.71.
In other Colgate-Palmolive news, COO Noel R. Wallace sold 126,304 shares of the firm’s stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $73.78, for a total value of $9,318,709.12. Following the completion of the sale, the chief operating officer now directly owns 305,631 shares of the company’s stock, valued at approximately $22,549,455.18. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Henning I. Jakobsen sold 36,215 shares of the firm’s stock in a transaction on Monday, February 5th. The stock was sold at an average price of $71.22, for a total value of $2,579,232.30. Following the completion of the sale, the vice president now directly owns 70,783 shares of the company’s stock, valued at $5,041,165.26. The disclosure for this sale can be found here. Insiders sold a total of 414,019 shares of company stock worth $29,541,377 in the last 90 days. 1.02% of the stock is currently owned by insiders.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.